ATE273307T1 - Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren - Google Patents

Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren

Info

Publication number
ATE273307T1
ATE273307T1 AT98932715T AT98932715T ATE273307T1 AT E273307 T1 ATE273307 T1 AT E273307T1 AT 98932715 T AT98932715 T AT 98932715T AT 98932715 T AT98932715 T AT 98932715T AT E273307 T1 ATE273307 T1 AT E273307T1
Authority
AT
Austria
Prior art keywords
cycloheptapyridine
benzo
protein transferase
transferase inhibitors
farnesyl protein
Prior art date
Application number
AT98932715T
Other languages
English (en)
Inventor
Dinanath F Rane
Stacy W Remiszewski
Ronald J Doll
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE273307T1 publication Critical patent/ATE273307T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98932715T 1997-06-17 1998-06-15 Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren ATE273307T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/877,366 US5939416A (en) 1997-06-17 1997-06-17 Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
PCT/US1998/011505 WO1998057970A1 (en) 1997-06-17 1998-06-15 Benzo(5,6)cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors

Publications (1)

Publication Number Publication Date
ATE273307T1 true ATE273307T1 (de) 2004-08-15

Family

ID=25369837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932715T ATE273307T1 (de) 1997-06-17 1998-06-15 Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren

Country Status (12)

Country Link
US (1) US5939416A (de)
EP (1) EP1019400B1 (de)
JP (1) JP3258342B2 (de)
CN (1) CN1119345C (de)
AR (1) AR012990A1 (de)
AT (1) ATE273307T1 (de)
AU (1) AU8253398A (de)
CA (1) CA2293711C (de)
DE (1) DE69825608T2 (de)
ES (1) ES2221989T3 (de)
WO (1) WO1998057970A1 (de)
ZA (1) ZA985211B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6271378B1 (en) 1998-12-18 2001-08-07 Schering Corporation Process for preparing tricyclic compounds having antihistaminic activity
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
PE20020635A1 (es) 2000-11-29 2002-07-11 Schering Corp Compuestos triciclicos como inhibidores de la farnesil transferasa
WO2005089518A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Uch-l1 expression and cancer therapy
WO2005089496A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
US20060194821A1 (en) * 2005-02-18 2006-08-31 The Brigham And Women's Hospital, Inc. Compounds inhibiting the aggregation of superoxide dismutase-1
US20070148660A1 (en) * 2005-06-16 2007-06-28 The Regents Of The University Of California Treatment of maladaptive substance use with H-ras antagonists
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2370436A1 (de) 2008-11-13 2011-10-05 Link Medicine Corporation Azachinolinonderivate und deren verwendungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5721236A (en) * 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
KR20000036120A (ko) * 1996-09-13 2000-06-26 둘락 노먼 씨. 파르네실 단백질 트랜스퍼라제에 대한 트리사이클릭 저해제
CA2266014A1 (en) * 1996-09-13 1998-03-19 Schering Corporation Tricyclic compounds useful for inhibition of farnesyl protein transferase

Also Published As

Publication number Publication date
AU8253398A (en) 1999-01-04
EP1019400A1 (de) 2000-07-19
DE69825608T2 (de) 2005-08-04
ES2221989T3 (es) 2005-01-16
WO1998057970A1 (en) 1998-12-23
CA2293711C (en) 2004-08-24
DE69825608D1 (de) 2004-09-16
AR012990A1 (es) 2000-11-22
CA2293711A1 (en) 1998-12-23
JP2000513034A (ja) 2000-10-03
US5939416A (en) 1999-08-17
CN1119345C (zh) 2003-08-27
JP3258342B2 (ja) 2002-02-18
ZA985211B (en) 1998-12-15
CN1267302A (zh) 2000-09-20
EP1019400B1 (de) 2004-08-11

Similar Documents

Publication Publication Date Title
ATE185341T1 (de) 4,9-ethano-benzo(f)isoindolderivate als farnesyl transferase inhibitoren
ATE321757T1 (de) (imidazol-5-yl)methyl-2-chinolinonderivate als farnesyl protein transferase inhibitoren
NO996571D0 (no) Inhibitorer for farnesyl-protein-transferase
DE69907964D1 (de) 1,2-annelierte chinolinderivate
DE69728676D1 (de) Substituierte 6,6-heterobicyclische derivate
ID29311A (id) Aturan penentuan quinolat posporibosil transferase
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
EE04309B1 (et) Farnesüül-proteiini transferaasi inhibiitorid
EE9800408A (et) Proteiinfarnesüültransferaasi inhibiitorid
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
DE69711020D1 (de) Thiazole derivate als protein kinase c inhibitoren
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69924876D1 (de) Farnesyl protein transferase inhibitoren
ATE387448T1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ATE273307T1 (de) Benzo(5,6)cycloheptapyridin derivate anwendbar als farnesyl protein transferase inhibitoren
ATE240317T1 (de) Indolderivate als pkc-inhibitoren
ATE273299T1 (de) Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
ATE222905T1 (de) Benzo(5,6)cyclohepta(1,2-b)pyridine derivate als farnesyl protein transferase inhibitoren
DE69907254D1 (de) 6-azauracilderivate als il-5 inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties